STOCK TITAN

[S-8 POS] NV5 Global, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Select Medical Holdings (SEM) Form 4: On 08/01/2025 Chief Information Officer Brian R. Rusignuolo surrendered 14,680 shares of common stock at $12.57 each. The disposition is coded F, meaning the shares were withheld by the company solely to cover federal and state tax obligations arising from the vesting of restricted stock; no open-market sale occurred.

After the withholding, the insider directly owns 361,370 SEM shares. The forfeited shares equate to roughly 3.9 % of his post-vest holdings (≈376,050 shares before withholding), indicating he retains a substantial equity position.

The filing appears routine and carries limited informational content for the firm’s operating outlook because it reflects a tax-driven administrative action rather than a discretionary buy or sell decision.

Select Medical Holdings (SEM) Modulo 4: Il 01/08/2025 il Chief Information Officer Brian R. Rusignuolo ha ceduto 14.680 azioni ordinarie al prezzo di 12,57$ ciascuna. La cessione è codificata come F, il che significa che le azioni sono state trattenute dalla società esclusivamente per coprire le imposte federali e statali derivanti dal vesting delle azioni vincolate; non si è verificata alcuna vendita sul mercato aperto.

Dopo la trattenuta, l’insider possiede direttamente 361.370 azioni SEM. Le azioni trattenute corrispondono a circa il 3,9% delle sue partecipazioni post-vesting (circa 376.050 azioni prima della trattenuta), indicando che mantiene una posizione azionaria significativa.

La comunicazione sembra di routine e ha un contenuto informativo limitato riguardo alle prospettive operative dell’azienda, poiché riflette una procedura amministrativa legata alle imposte e non una decisione discrezionale di acquisto o vendita.

Select Medical Holdings (SEM) Formulario 4: El 01/08/2025, el Director de Información Brian R. Rusignuolo entregó 14.680 acciones ordinarias a 12,57$ cada una. La disposición está codificada como F, lo que significa que las acciones fueron retenidas por la empresa únicamente para cubrir obligaciones fiscales federales y estatales derivadas del vesting de acciones restringidas; no se realizó ninguna venta en el mercado abierto.

Después de la retención, el insider posee directamente 361.370 acciones de SEM. Las acciones retenidas equivalen aproximadamente al 3,9 % de sus tenencias posteriores al vesting (≈376.050 acciones antes de la retención), lo que indica que mantiene una posición accionaria sustancial.

La presentación parece rutinaria y tiene un contenido informativo limitado respecto a las perspectivas operativas de la empresa, ya que refleja una acción administrativa motivada por impuestos y no una decisión discrecional de compra o venta.

Select Medical Holdings (SEM) Form 4: 2025년 8월 1일, 최고정보책임자 Brian R. Rusignuolo가 보통주 14,680주를 각각 $12.57에 양도했습니다. 처분은 F 코드로 표시되었으며, 이는 제한 주식의 베스팅에 따른 연방 및 주 세금 의무를 충당하기 위해 회사가 주식을 보유했음을 의미하며, 공개 시장에서의 매도는 없었습니다.

원천징수 후 내부자는 직접 361,370 SEM 주식을 보유하고 있습니다. 몰수된 주식은 베스팅 후 보유 주식의 약 3.9%에 해당하며(원천징수 전 약 376,050주), 상당한 지분을 유지하고 있음을 나타냅니다.

이 신고는 일상적인 것으로 보이며, 회사의 운영 전망에 대한 정보는 제한적입니다. 이는 임의의 매매 결정이 아닌 세금 관련 행정 조치를 반영하기 때문입니다.

Select Medical Holdings (SEM) Formulaire 4 : Le 01/08/2025, le Directeur des Systèmes d'Information Brian R. Rusignuolo a cédé 14 680 actions ordinaires au prix de 12,57 $ chacune. La transaction est codée F, ce qui signifie que les actions ont été retenues par la société uniquement pour couvrir les obligations fiscales fédérales et étatiques liées à l'acquisition des actions restreintes ; aucune vente sur le marché libre n'a eu lieu.

Après cette retenue, l'initié détient directement 361 370 actions SEM. Les actions retenues représentent environ 3,9 % de ses avoirs post-acquisition (≈376 050 actions avant retenue), indiquant qu'il conserve une position significative en capital.

Le dépôt semble routinier et apporte peu d'informations sur les perspectives opérationnelles de l'entreprise, car il reflète une action administrative liée à la fiscalité plutôt qu'une décision discrétionnaire d'achat ou de vente.

Select Medical Holdings (SEM) Formular 4: Am 01.08.2025 hat Chief Information Officer Brian R. Rusignuolo 14.680 Stammaktien zu je 12,57$ abgegeben. Die Transaktion ist mit F codiert, was bedeutet, dass die Aktien vom Unternehmen ausschließlich zur Deckung der bundes- und staatlichen Steuerverpflichtungen aus der Vesting von eingeschränkten Aktien einbehalten wurden; kein Verkauf am offenen Markt fand statt.

Nach der Einbehaltung besitzt der Insider direkt 361.370 SEM-Aktien. Die einbehaltenen Aktien entsprechen etwa 3,9 % seines Bestands nach dem Vesting (≈376.050 Aktien vor der Einbehaltung), was darauf hinweist, dass er eine bedeutende Beteiligung hält.

Die Meldung erscheint routinemäßig und enthält nur begrenzte Informationen zur operativen Prognose des Unternehmens, da sie eine steuerbedingte administrative Maßnahme und keine freiwillige Kauf- oder Verkaufsentscheidung widerspiegelt.

Positive
  • Insider retains a sizeable 361,370-share stake, maintaining alignment with shareholder interests
  • Transaction is tax-related; not an open-market sale, so it does not add selling pressure
Negative
  • Net share count for the insider decreased by 14,680 shares, a 3.9 % reduction in personal holdings
  • No insider purchase activity that could signal confidence or undervaluation

Insights

TL;DR: Tax-withholding share surrender; neutral signal, insider still owns 361k shares.

This Form 4 shows a typical Code F transaction—shares withheld to satisfy taxes on restricted-stock vesting. Such events neither inject shares into the market nor signal insider sentiment. Rusignuolo’s residual 361,370-share position aligns his incentives with shareholders and indicates continued confidence in SEM’s prospects. Because there is no open-market activity or option exercise, the impact on float, liquidity, and valuation is essentially nil. I therefore classify the market impact as neutral.

Select Medical Holdings (SEM) Modulo 4: Il 01/08/2025 il Chief Information Officer Brian R. Rusignuolo ha ceduto 14.680 azioni ordinarie al prezzo di 12,57$ ciascuna. La cessione è codificata come F, il che significa che le azioni sono state trattenute dalla società esclusivamente per coprire le imposte federali e statali derivanti dal vesting delle azioni vincolate; non si è verificata alcuna vendita sul mercato aperto.

Dopo la trattenuta, l’insider possiede direttamente 361.370 azioni SEM. Le azioni trattenute corrispondono a circa il 3,9% delle sue partecipazioni post-vesting (circa 376.050 azioni prima della trattenuta), indicando che mantiene una posizione azionaria significativa.

La comunicazione sembra di routine e ha un contenuto informativo limitato riguardo alle prospettive operative dell’azienda, poiché riflette una procedura amministrativa legata alle imposte e non una decisione discrezionale di acquisto o vendita.

Select Medical Holdings (SEM) Formulario 4: El 01/08/2025, el Director de Información Brian R. Rusignuolo entregó 14.680 acciones ordinarias a 12,57$ cada una. La disposición está codificada como F, lo que significa que las acciones fueron retenidas por la empresa únicamente para cubrir obligaciones fiscales federales y estatales derivadas del vesting de acciones restringidas; no se realizó ninguna venta en el mercado abierto.

Después de la retención, el insider posee directamente 361.370 acciones de SEM. Las acciones retenidas equivalen aproximadamente al 3,9 % de sus tenencias posteriores al vesting (≈376.050 acciones antes de la retención), lo que indica que mantiene una posición accionaria sustancial.

La presentación parece rutinaria y tiene un contenido informativo limitado respecto a las perspectivas operativas de la empresa, ya que refleja una acción administrativa motivada por impuestos y no una decisión discrecional de compra o venta.

Select Medical Holdings (SEM) Form 4: 2025년 8월 1일, 최고정보책임자 Brian R. Rusignuolo가 보통주 14,680주를 각각 $12.57에 양도했습니다. 처분은 F 코드로 표시되었으며, 이는 제한 주식의 베스팅에 따른 연방 및 주 세금 의무를 충당하기 위해 회사가 주식을 보유했음을 의미하며, 공개 시장에서의 매도는 없었습니다.

원천징수 후 내부자는 직접 361,370 SEM 주식을 보유하고 있습니다. 몰수된 주식은 베스팅 후 보유 주식의 약 3.9%에 해당하며(원천징수 전 약 376,050주), 상당한 지분을 유지하고 있음을 나타냅니다.

이 신고는 일상적인 것으로 보이며, 회사의 운영 전망에 대한 정보는 제한적입니다. 이는 임의의 매매 결정이 아닌 세금 관련 행정 조치를 반영하기 때문입니다.

Select Medical Holdings (SEM) Formulaire 4 : Le 01/08/2025, le Directeur des Systèmes d'Information Brian R. Rusignuolo a cédé 14 680 actions ordinaires au prix de 12,57 $ chacune. La transaction est codée F, ce qui signifie que les actions ont été retenues par la société uniquement pour couvrir les obligations fiscales fédérales et étatiques liées à l'acquisition des actions restreintes ; aucune vente sur le marché libre n'a eu lieu.

Après cette retenue, l'initié détient directement 361 370 actions SEM. Les actions retenues représentent environ 3,9 % de ses avoirs post-acquisition (≈376 050 actions avant retenue), indiquant qu'il conserve une position significative en capital.

Le dépôt semble routinier et apporte peu d'informations sur les perspectives opérationnelles de l'entreprise, car il reflète une action administrative liée à la fiscalité plutôt qu'une décision discrétionnaire d'achat ou de vente.

Select Medical Holdings (SEM) Formular 4: Am 01.08.2025 hat Chief Information Officer Brian R. Rusignuolo 14.680 Stammaktien zu je 12,57$ abgegeben. Die Transaktion ist mit F codiert, was bedeutet, dass die Aktien vom Unternehmen ausschließlich zur Deckung der bundes- und staatlichen Steuerverpflichtungen aus der Vesting von eingeschränkten Aktien einbehalten wurden; kein Verkauf am offenen Markt fand statt.

Nach der Einbehaltung besitzt der Insider direkt 361.370 SEM-Aktien. Die einbehaltenen Aktien entsprechen etwa 3,9 % seines Bestands nach dem Vesting (≈376.050 Aktien vor der Einbehaltung), was darauf hinweist, dass er eine bedeutende Beteiligung hält.

Die Meldung erscheint routinemäßig und enthält nur begrenzte Informationen zur operativen Prognose des Unternehmens, da sie eine steuerbedingte administrative Maßnahme und keine freiwillige Kauf- oder Verkaufsentscheidung widerspiegelt.

As filed with the Securities and Exchange Commission on August 4, 2025

 

Registration Statement No. 333-187963

Registration Statement No. 333-212150

Registration Statement No. 333-212159

Registration Statement No. 333-233627

Registration Statement No. 333-272900

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT NO. 333-187963

POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT NO. 333-212150

POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT NO. 333-212159

POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT NO. 333-233627

POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 REGISTRATION STATEMENT NO. 333-272900

 

UNDER

THE SECURITIES ACT OF 1933

 

NV5 Global, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   45-3458017
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

200 South Park Road, Suite 350    
Hollywood, Florida   33021
(Address of principal executive offices)   (Zip Code)

 

NV5 Global, Inc. 2023 Equity Incentive Plan

NV5 Global, Inc. Employee Stock Purchase Plan

NV5 Global, Inc. 2011 Equity Incentive Plan, as amended

(Full Title of the Plans)

 

Richard Tong, Esq.

Executive Vice President and General Counsel

NV5 Global, Inc.

200 South Park Road, Suite 350

Hollywood, Florida 33021

(954) 495-2112

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

Mitchell Nussbaum, Esq.
Norwood Beveridge, Esq.
Lili Taheri, Esq.
Loeb & Loeb LLP
345 Park Avenue
New York, New York 10154
Phone: (212) 407-4000

Fax: (212) 407-4990

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer Accelerated Filer Non-accelerated filer Smaller reporting company
Emerging growth company            

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

 

 

EXPLANATORY NOTE

 

DEREGISTRATION OF UNSOLD SECURITIES

 

NV5 Global, Inc., a Delaware corporation (“NV5”), is filing these post-effective amendments (these “Post-Effective Amendments”) to the following Registration Statements on Form S-8 (each, a “Registration Statement” and collectively, the “Registration Statements”), which were filed by NV5 with the Securities and Exchange Commission (the “SEC”) on the dates set forth below, to deregister any and all shares of common stock, par value $.01 per share (“Common Stock”), registered but unissued under each such Registration Statement as of the date hereof:

 

1.Registration Statement on Form S-8 (No. 333-187963), which was filed by NV5 with the SEC on April 17, 2013 registering 2,218,632 shares of Common Stock (after giving effect to the four-for-one split of the Common Stock occurring on October 9, 2024) under the NV5 Holdings, Inc. 2011 Equity Incentive Plan, as amended;

 

2.Registration Statement on Form S-8 (No. 333-212150), which was filed by NV5 with the SEC on June 21, 2016, registering 2,714,564 shares of Common Stock (after giving effect to the four-for-one split of the Common Stock occurring on October 9, 2024) under the NV5 Global, Inc. 2011 Equity Incentive Plan, as amended;

 

3.Registration Statement on Form S-8 (No. 333-212159), which was filed by NV5 with the SEC on June 21, 2016, registering 2,000,000 shares of Common Stock (after giving effect to the four-for-one split of the Common Stock occurring on October 9, 2024) under the NV5 Global, Inc. Employee Stock Purchase Plan;

 

4.Registration Statement on Form S-8 (No. 333-233627), which was filed by NV5 with the SEC on September 4, 2019, registering 4,753,728 shares of Common Stock (after giving effect to the four-for-one split of the Common Stock occurring on October 9, 2024) under the NV5 Global, Inc. 2011 Equity Incentive Plan, as amended; and

 

5.Registration Statement on Form S-8 (No. 333-272900), which was filed by NV5 with the SEC on June 23, 2023, registering 9,302,816 shares of Common Stock (after giving effect to the four-for-one split of the Common Stock occurring on October 9, 2024) under the NV5 Global, Inc. 2023 Equity Incentive Plan.

 

On August 4, 2025, pursuant to the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”), dated May 14, 2025, by and among Acuren Corporation, a Delaware corporation (“Acuren”), Ryder Merger Sub I, Inc., a Delaware corporation and direct wholly owned subsidiary of Acuren (“Merger Sub I”), Ryder Merger Sub II, Inc., a Delaware corporation and wholly owned direct, subsidiary of Acuren (“Merger Sub II”) and NV5, Merger Sub I merged with and into NV5, with NV5 surviving such merger as the surviving corporation (the “Initial Surviving Corporation”) and continuing as a direct wholly owned subsidiary of Acuren, and (ii) immediately thereafter, the Initial Surviving Corporation merged with and into Merger Sub II, with Merger Sub II continuing its existence as the surviving corporation as a direct wholly owned subsidiary of Acuren.

 

As a result of the completion of the transactions contemplated by the Merger Agreement, NV5 has terminated all offerings of Common Stock pursuant to the Registration Statements. In accordance with the undertakings made by NV5 in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that had been registered for issuance that remain unsold at the termination of such offerings, NV5 hereby removes from registration by means of these Post-Effective Amendments all shares of Common Stock registered but unsold under the Registration Statements as of the date hereof. The Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such shares of Common Stock and NV5 hereby terminates the effectiveness of the Registration Statements.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hollywood, State of Florida, on this 4th day of August, 2025.

 

  NV5 GLOBAL, INC.
   
  By: /s/ Richard Tong
  Name:  Richard Tong
  Title: Executive Vice President and General Counsel

 

Note: No other person is required to sign these Post-Effective Amendments to Form S-8 Registration Statements in reliance on Rule 478 under the Securities Act of 1933, as amended.

 

 

 

FAQ

What type of insider transaction did SEM report?

The filing shows a Code F (tax-withholding) surrender of restricted shares.

How many SEM shares were surrendered by the CIO?

Brian R. Rusignuolo surrendered 14,680 shares.

At what price were the shares valued for withholding purposes?

The shares were valued at $12.57 each.

How many SEM shares does the insider own after the transaction?

He directly owns 361,370 shares following the withholding.

Was the transaction an open-market sale?

No. Code F indicates the shares were withheld by the company for tax purposes.

When did the transaction occur?

The transaction date was 08/01/2025 and the Form 4 was signed on 08/04/2025.
Nv5 Global Inc

NASDAQ:NVEE

NVEE Rankings

NVEE Latest News

NVEE Latest SEC Filings

NVEE Stock Data

1.51B
57.41M
12.11%
76.03%
2.35%
Engineering & Construction
Services-miscellaneous Business Services
Link
United States
HOLLYWOOD